Inovio Pharmaceuticals
INO
#9653
Rank
โ‚ฌ79.98 M
Marketcap
0,97ย โ‚ฌ
Share price
0.45%
Change (1 day)
-42.96%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -2,53ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,51ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,44ย โ‚ฌ an increase over its 2023 EPS that were of -5,31ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,53ย โ‚ฌ-26.56%
2024-3,44ย โ‚ฌ-35.14%
2023-5,31ย โ‚ฌ-56.62%
2022-12,24ย โ‚ฌ-19.54%
2021-15,21ย โ‚ฌ35.9%
2020-11,20ย โ‚ฌ-11.57%
2019-12,66ย โ‚ฌ15.24%
2018-10,99ย โ‚ฌ-2.78%
2017-11,30ย โ‚ฌ6.93%
2016-10,57ย โ‚ฌ134.88%
2015-4,50ย โ‚ฌ-29.51%
2014-6,38ย โ‚ฌ-57.34%
2013-14,96ย โ‚ฌ146.55%
2012-6,07ย โ‚ฌ20.83%
2011-5,02ย โ‚ฌ-29.41%
2010-7,11ย โ‚ฌ-48.48%
2009-13,81ย โ‚ฌ10%
2008-12,56ย โ‚ฌ11.11%
2007-11,30ย โ‚ฌ-41.3%
2006-19,25ย โ‚ฌ-66.91%
2005-58,17ย โ‚ฌ110.61%
2004-27,62ย โ‚ฌ-61.63%
2003-71,98ย โ‚ฌ186.67%
2002-25,11ย โ‚ฌ
2001N/A-100%
2000-20,09ย โ‚ฌ-62.38%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,62ย โ‚ฌ-403.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,12ย โ‚ฌ-343.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,14ย โ‚ฌ-145.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5,97ย โ‚ฌ-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,10ย โ‚ฌ-223.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,39ย โ‚ฌ-234.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
0,31ย โ‚ฌ-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA